← Back to Analyst Consensus 
ABUS Buy
Arbutus Biopharma Corp
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Nov 14, 2025 | Chardan Capital | maintain | Buy → Buy | $5 | 47% |
| Aug 11, 2025 | Chardan Capital | maintain | Buy → Buy | $5 | 47% |
| Mar 28, 2025 | Chardan Capital | maintain | Buy → Buy | $5 | 47% |
| Jan 21, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Nov 20, 2024 | Chardan Capital | maintain | Buy → Buy | $5 | 47% |
| Nov 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Nov 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Nov 6, 2024 | Chardan Capital | maintain | Buy → Buy | $4.5 | 47% |
| Sep 5, 2024 | Jefferies | maintain | Buy → Buy | $7 | 52% |
| Aug 2, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $5 | 53% |
| Jun 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Jun 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Jun 5, 2024 | Chardan Capital | maintain | Buy → Buy | $4 | 47% |
| May 3, 2024 | Chardan Capital | reiterate | Buy → Buy | $4 | 47% |
| Apr 4, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $4 | 53% |
| Mar 1, 2024 | Chardan Capital | reiterate | Buy → Buy | $4 | 47% |
| Mar 1, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Sep 12, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Aug 4, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Aug 4, 2023 | Chardan Capital | reiterate | Buy → Buy | $6 | 47% |
| Jul 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Jul 6, 2023 | JMP Securities | reiterate | Market Outperform → Market Outperform | $6 | 53% |
| Jun 22, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Jun 22, 2023 | Chardan Capital | reiterate | Buy → Buy | $6 | 47% |
| May 5, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $6 | 44% |
| Apr 28, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $6 | 44% |
| Apr 5, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $6 | 44% |
| Mar 29, 2023 | JMP Securities | reiterate | — → Market Outperform | $6 | 53% |
| Mar 20, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $6 | 44% |
| Mar 3, 2023 | Chardan Capital | reiterate | — → Buy | $6 | 47% |
| Mar 3, 2023 | HC Wainwright & Co. | maintain | — → Buy | $6 | 44% |
| Nov 10, 2022 | HC Wainwright & Co. | maintain | — → Buy | $6 | 44% |
| Jun 28, 2022 | JMP Securities | maintain | — → Market Outperform | $9 | 53% |
| Mar 14, 2022 | HC Wainwright & Co. | maintain | — → Buy | $8.5 | 44% |
| Mar 4, 2022 | Chardan Capital | maintain | — → Buy | $6 | 47% |
| Feb 2, 2022 | Jefferies | upgrade | Hold → Buy | $5 | 52% |
| Nov 8, 2021 | JMP Securities | maintain | — → Market Outperform | $9 | 53% |
| Dec 17, 2020 | HC Wainwright & Co. | initiate | — → Buy | $10 | 44% |
| Jul 24, 2020 | Baird | downgrade | Outperform → Neutral | $0 | 55% |
| May 19, 2020 | Wedbush | upgrade | Neutral → Outperform | $4 | 58% |
| Mar 27, 2020 | Baird | maintain | — → Outperform | $4 | 55% |
| Mar 6, 2020 | Chardan Capital | upgrade | Neutral → Buy | $5 | 47% |
| Feb 20, 2020 | Baird | initiate | — → Outperform | $8 | 55% |
| Feb 5, 2020 | JMP Securities | upgrade | Market Perform → Market Outperform | $10 | 53% |
| Jan 9, 2020 | B. Riley Securities | maintain | — → Buy | $6 | 55% |
| Oct 4, 2019 | Chardan Capital | downgrade | Buy → Neutral | $0 | 47% |
| Oct 16, 2018 | B. Riley Securities | upgrade | Neutral → Buy | $9 | 55% |
| Oct 15, 2018 | Wedbush | upgrade | Underperform → Neutral | $5 | 58% |
| Aug 13, 2018 | B. Riley Securities | maintain | Neutral → Neutral | $11.5 | 55% |
| Aug 13, 2018 | Wedbush | maintain | Neutral → Neutral | $7 | 58% |
Price Target Trend
May 5, 2026 Latest: $5.45 Oct 25, 2026
EPS Estimates
0y $1.03
Lo: $1.03 Hi: $1.03
1 analysts ▲1
0q $-0.03
Lo: $-0.03 Hi: $-0.03
1 analysts +1y $-0.11
Lo: $-0.11 Hi: $-0.11
1 analysts ▲1
+1q $-0.03
Lo: $-0.03 Hi: $-0.03
1 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days